AREC.L
Arecor Therapeutics PLC
Price:  
76.50 
GBP
Volume:  
371.00
United Kingdom | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AREC.L Probability of Bankruptcy

The Probability of Bankruptcy of Arecor Therapeutics PLC (AREC.L) is -% . This number represents the probability that AREC.L will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating AREC.L's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

AREC.L - ESG ratings

ESG ratings are directly linked to the cost of capital and AREC.L's ability to raise funding, both of which can significantly affect the probability of Arecor Therapeutics PLC going bankrupt.

ESG Score -
Environment Score -
Social Score -
Governance Score -
Returns
Historical Returns (5 day) -%
Historical Returns (MTD) -%
Historical Returns (YTD) -58.08%
Historical Returns (13 week) -4.37%
Historical Returns (26 week) -40.00%
Historical Returns (52 week) -58.08%
Efficiency
Asset Turnover 0.51
Receiveable Turnover
Gross Margin
Operating Margin -137.85%
Pretax Margin -135.37%
Net Margin -131.94%
Return on Asset (ROA) -67.33
Return on Equity (ROE) -118.67
Return on Investments (ROI) -113.85
Price Metrics
Market Cap (M) 28.88
Enterprise Value (M)
52 Week High 185.00
52 Week Low 62.55
Beta 0.61
Average Volume (10 day) 0.00
Average Volume (3 month) 0.01
Price / Earnings (P/E)
Price / Sales (P/S) 4.40
Earnings
EPS -0.28
Revenue CAGR (5 year) 27.64%
Risk
Current Ratio 1.37
Quick Ratio 1.08